Research and treatments
Crispr therapies in the media
https://www.createdigital.org.au/research-warning-crispr-therapies/?utm_source=facebook.com&utm_medium=sponsored-social&utm_campaign=engagement&utm_content=lookalike-fbengaged
Status on Consensus Paper for Physical Rehabilitation in OI
Below is a link to the Care4BrittleBones newsletter which outlines the development a project aimed at developing a worldwide consensus …
New Publication from The Osteogenesis Imperfecta Federation
Physical and Occupational Therapists Guide to Treating Osteogenesis Imperfecta BY The Osteogenesis Imperfecta Federation (OIF) USA Key Principles and Therapeutic …
The OI Foundation Research Announcement
A new study through the OI Foundation in America, is open for biological parents with osteogenesis imperfecta (OI) and biological …
Brittle Bone Consortium
As discussed at the conference we are encouraged to participate in any and all self report studies about people with …
Combination sclerostin antibody and zoledronic acid treatment outperforms either treatment alone in a mouse model of osteogenesis imperfecta
In this study, we examined the therapeutic potential of anti-Sclerostin Antibody (Scl-Ab) and bisphosphonate treatments for the bone fragility disorder …
Update on Bisphosphonates as a Treatment for Osteogenesis Imperfecta
This information update was prepared by the OI Foundation’s Medical Advisory Council. Since the early 1990’s a class of drugs …
Update on OI Society Sponsored Research
Research is still continuing at The Children’s Hospital at Westmead, in conjunction with Macquarie University, investigating physical activity participation of …
OI Society of Australia Sponsored Research
In 2016 the OI Society of Australia is funding the following research. Physical Activity in Children with Osteogenesis Imperfecta. What …